- Home
- PEN vs ALLY Comparison
PEN vs ALLY Comparison
Compare PEN & ALLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- ALLY
- Stock Information
- Founded
- PEN 2004
- ALLY 1919
- Country
- PEN United States
- ALLY United States
- Employees
- PEN N/A
- ALLY N/A
- Industry
- PEN Medical/Dental Instruments
- ALLY Major Banks
- Sector
- PEN Health Care
- ALLY Finance
- Exchange
- PEN Nasdaq
- ALLY Nasdaq
- Market Cap
- PEN 10.5B
- ALLY 11.4B
- IPO Year
- PEN 2015
- ALLY 2014
- Fundamental
- Price
- PEN $277.35
- ALLY $31.63
- Analyst Decision
- PEN Strong Buy
- ALLY Buy
- Analyst Count
- PEN 16
- ALLY 20
- Target Price
- PEN $290.93
- ALLY $43.00
- AVG Volume (30 Days)
- PEN 451.5K
- ALLY 5.9M
- Earning Date
- PEN 04-23-2025
- ALLY 04-17-2025
- Dividend Yield
- PEN N/A
- ALLY 3.79%
- EPS Growth
- PEN N/A
- ALLY N/A
- EPS
- PEN 0.36
- ALLY 0.62
- Revenue
- PEN $1,194,615,000.00
- ALLY $6,658,000,000.00
- Revenue This Year
- PEN $14.26
- ALLY $27.48
- Revenue Next Year
- PEN $14.21
- ALLY $9.42
- P/E Ratio
- PEN $762.38
- ALLY $50.76
- Revenue Growth
- PEN 12.86
- ALLY N/A
- 52 Week Low
- PEN $148.00
- ALLY $29.52
- 52 Week High
- PEN $310.00
- ALLY $45.46
- Technical
- Relative Strength Index (RSI)
- PEN 53.70
- ALLY 38.86
- Support Level
- PEN $253.27
- ALLY $30.26
- Resistance Level
- PEN $278.39
- ALLY $32.83
- Average True Range (ATR)
- PEN 14.09
- ALLY 1.95
- MACD
- PEN 0.97
- ALLY -0.19
- Stochastic Oscillator
- PEN 90.04
- ALLY 27.16
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.